World Renowned Cancer Researchers From Spain and U.S. Join Forces to Address Critical Needs and Challenges in Women’s Cancer Research

By : Nata Kesuma | Saturday, December 09 2023 - 09:58 IWST

World Renowned Cancer Researchers From Spain and U.S. Join Forces to Address Critical Needs and Challenges in Women’s Cancer Research
World Renowned Cancer Researchers From Spain and U.S. Join Forces to Address Critical Needs and Challenges in Women’s Cancer Research - Dallas - Mary Kay Inc., the world's No. 1 direct selling skin care and color cosmetics brand1 and its company-sponsored foundations, including the Mary Kay Ash Foundation in the U.S., continue to provide unwavering support to women’s cancer research through funding a variety of research programs and projects, awarding grants to world renowned scientists, and facilitating clinical trials, all in the name of finding a cure.

Mary Kay recently hosted a virtual meeting between Dr. Joyce O'Shaughnessy, Celebrating Women Endowed Chair in Breast Cancer Research at Baylor University Medical Center and Chair, Breast Cancer Research at U.S. Oncology based in Dallas, Texas, and Dr. Eva Ciruelos, Breast Cancer Unit Coordinator, University Hospital and HM Hospitals and Chair, SOLTI Group on Breast Cancer Research, and FERO Foundation grant recipient supported by Mary Kay Spain, based in Madrid, Spain. Both lead their own research teams in their respective home countries focused on investigating the rare and aggressive form of cancer in women: triple negative metastatic breast cancer (TNBC). Despite being separated by thousands of miles, the two go way back - they have collaborated for years on TNBC research in their fight to find solutions and a cure for this devastating disease.

The two leading researchers and experts in their respective fields sat down to discuss the importance of global scientific collaboration, in which they stressed the urgency for researchers worldwide to share their findings and advances to pool results.

”It is not a matter of having the best idea, but of arriving together to obtain the best treatment for each patient, and this is something that must permeate the medical, clinical, and pharmaceutical industries. The incidence of breast cancer in women is seeing an upward trend in the world, and today we can say that 1 in 3 women will be diagnosed with cancer in their lifetime2,” said Dr. O’Shaughnessy.

”Without continuous collaboration among all the experts, it would be impossible to arrive at specific diagnoses,” commented Dr. Ciruelos. ”It is vital to follow up each patient's treatment in a personalized way; only then will we be able to detect why the same treatment for people with similar characteristics works for some, but not for others.”

They confirmed their frustration with the differences and inconsistencies they see in access to therapies, drugs, and treatments within various countries and called for unity in offering more consistent treatment for all patients regardless of their place of living. The two researchers also agreed that it is challenging to find time to fully dedicate themselves to cancer research as they have to deal with funding challenges and expressed their gratitude to their sponsors, including the Mary Kay Ash Foundation and Fero Foundation who make their life-saving work possible.

Dr. O'Shaughnessy added, “In 1985, we were terribly frustrated by the lack of therapeutic options for women with cancer. Today, we are seeing great advances on this front and I’m very optimistic for the success of the next generation of researchers.”

Through the funding of cancer research projects by the Mary Kay Ash Foundation in the United States and Mary Kay Spain’s grant award to FERO Foundation in Spain, Dr. O’Shaughnessy and Dr. Ciruelos have been able to continue collaborating on their life’s work. Mary Kay is at the forefront of women's cancer research, supporting groundbreaking research led by women for women. Mary Kay is committed to helping researchers around the world by supporting translational research (research that links laboratory research directly to the patient), clinical trials aimed at improving the detection, prognosis, and treatment of women's cancers, as well as organizations that support cancer research, such as the FERO Foundation in Spain.

News Comment

Today's Industry

The President Director of PT Trimegah Sekuritas Indonesia Tbk (TRIM), Philmon Tanuri (left) delivered remarks at the kick off of Trimegah's collaboration with IA SBM-ITB in Jakarta on Wednesday (05/06/2024).

Jumat, 07 Juni 2024 - 19:43 WIB

Trimegah Sekuritas Supports Ikatan Alumni SBM-ITB to Realise Lifelong Learning Mission

In order to realise its mission of “Educate and create wealth for community through unique and professional investment experience”, PT Trimegah Sekuritas Indonesia Tbk (TRIM) collaborates…

Presiden Jokowi

Selasa, 23 April 2024 - 10:29 WIB

President Jokowi Reaffirms Commitment to Farmers’ Welfare

President Joko “Jokowi” Widodo on Monday (04/22) inspected corn harvest in Boalemo regency, Gorontalo province. “Our corn import has decreased significantly from 3.5 million tonnes to…

Photo: Aris Nurjani/VOI

Rabu, 28 Februari 2024 - 12:47 WIB

Carsurin and NBRI Strengthen Strategic Alliance to Propel Indonesia’s EV Industry

PT Carsurin Tbk ("Carsurin") and the National Battery Research Institute ("NBRI") are pleased to announce the signing of a pivotal Strategic Alliance Agreement (SAA), marking a significant advancement…

Beras (Foto/Rizki Meirino)

Rabu, 21 Februari 2024 - 08:43 WIB

Gov’t to Continue Disbursing Rice Assistance

President Joko “Jokowi” Widodo has ensured that the Government will continue rolling out the rice assistance program for low-income families. The President made the statement when handing…

Ilustrasi pabrik beras. (Foto: DetikFood)

Rabu, 21 Februari 2024 - 08:40 WIB

Bapanas Head Ensures Availability of Rice Stock Ahead of Ramadan

The National Food Agency (Bapanas) has ensured the availability of rice for the fasting month of Ramadan and Eid al-Fitr 1445 Hijri/2024 CE. “We believe that there is enough rice for the fasting…